Fetal outcome after technetium scintigraphy in early pregnancy

Reproductive Toxicology

Volumn 28, Issue 2, 2009, Pages 161-166

  Schaefer, Christof ^a   Meister, Reinhard ^b   Wentzeck, René ^b   Weber Schoendorfer, Corinna ^a  

^a Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy   (Germany)

^b BEUTH UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Cohort study; Fetal outcome; Human; Pregnancy; Pregnancy outcome; Scintigraphy; Tc 99m; Technetium

Indexed keywords

PERTECHNETIC ACID TC 99M; TECHNETIUM 99M;

ARTICLE; BIRTH DEFECT; BONE SCINTISCANNING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GERMANY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PATIENT EDUCATION; PATIENT SAFETY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SPONTANEOUS ABORTION; TERATOGENESIS; THYROID SCINTISCANNING;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; FEMALE; FETAL DEVELOPMENT; GERMANY; GESTATIONAL AGE; HUMANS; MATERNAL EXPOSURE; ORGANOTECHNETIUM COMPOUNDS; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; YOUNG ADULT;

EID: 67650627732     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2009.05.001     Document Type: Article

References (23)

1. Russell J.R., Stabin M.G., and Sparks R.B. Placental transfer of radiopharmaceuticals and dosimetry in pregnancy. Health Phys. 73 (1997) 747-755
2. McAfee J.G., Stern H.S., Fueger G.F., Baggish M.S., Holzman G.B., and Zolle I. 99m-Tc labeled serum albumin for scintillation scanning of the placenta. J. Nucl. Med. 5 (1964) 936-946
3. Gilbert W.M., Newman P.S., Eby-Wilkens E., and Brace R.A. Technetium Tc 99m rapidly crosses the ovine placenta and intramembranous pathway. Am. J. Obstet. Gynecol. 175 (1996) 1557-1562
4. Owunwanne A., Omu A., Patel M., Mathew M., Ayesha A., and Gopinath S. Placental binding and transfer of radiopharmaceuticals: technetium-99m d, 1-HMPAO. J. Nucl. Med. 39 (1998) 1810-1813
5. Wegst A.V., Goin J.E., and Robinson R.G. Cumulated activities determined from biodistribution data in pregnant rats ranging from 13 to 21 days gestation. I. Tc-99m pertechnate. Med. Phys. 10 (1983) 841-845
6. Adelstein S.J. Administered radionuclides in pregnancy. Teratology 59 (1999) 236-239
7. Russell J.R., Stabin M.G., Sparks R.B., and Watson E. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys. 73 (1997) 756-769
8. Husák V., and Wiedermann M. Radiation absorbed dose estimates to the embryo from some nuclear medicine procedures. Eur. J. Nucl. Med. 5 (1980) 205-207
9. Marcus C.S., Mason G.R., Kuperus J.H., and Mena I. Pulmonary imaging in pregnancy. Maternal risk and fetal dosimetry. Clin. Nucl. Med. 10 (1985) 1-4
10. Smith T., Zanelli G.D., and Veall N. Radiation absorbed dose from technetium-99m DTPA. J. Nucl. Med. 28 (1987) 240-243
11. Hedrick W.R., DiSimone R.N., Wolf B.H., and Langer A. Absorbed dose to the fetus during bone scintigraphy. Radiology 168 (1988) 245-248
12. Steenvoorde P., Pauwels E.K.J., Harding L.K., Bourguignon M., Mariere B., and Broerse J.J. Diagnostic nuclear medicine and risk for the fetus. Eur. J. Nucl. Med. 25 (1998) 193-199
13. Merks J.H.M., van Karnebeek C.D.M., Caron H.N., and Hennekam R.C.M. Phenotypic abnormalities: terminology and classification. Am. J. Med. Genet. 123A (2003) 211-230
14. Rasmussen S.A., Olney R.S., Holmes L.B., Lin A.E., Keppler-Noreuil K.M., and Moore C.A. Guidelines for case classification for the national birth defects prevention study. Birth Defects Res. A. 67 (2003) 193-201
15. Meister R., and Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies-analyzing pregnancies exposed to coumarin derivatives. Reprod. Toxicol. 26 (2008) 31-35
16. R. Development Core Team, 2008. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL: http://www.R-project.org.
17. Holmes L.B. Need for inclusion and exclusion criteria for the structural abnormalities recorded in children born from exposed pregnancies. Teratology 64 (1999) 79-82
18. Johnson K.A., Weber P.A., Jones K.L., and Chambers C.D. Selection bias in teratology information service pregnancy outcome studies. Teratology 64 (2001) 79-82
19. Martinez-Frias M.L., and Rodriguez-Pinilla E. The problems of using data from teratology information services (TIS) to identify putative teratogens. Teratology 60 (1999) 54-55
20. Ornoy A., and Mastroiacovo P. More on data from teratogen information systems (TIS). Teratology 61 (2000) 327-328
21. David M., Pachaly J., and Vetter K. Perinatal outcome in Berlin (Germany) among immigrants from Turkey. Arch. Gynecol. Obstet. 274 (2006) 271-278
22. Schaefer C., Ornoy A., Clementi M., Meister R., and Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome-methodological considerations. Reprod. Toxicol. 26 (2008) 36-41
23. Stabin M.G., Watson E.E., Marcus C.S., and Salk R.D. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism. J. Nucl. Med. 32 (1991) 808-813